S

Swedencare AB (publ)
STO:SECARE

Watchlist Manager
Swedencare AB (publ)
STO:SECARE
Watchlist
Price: 48.96 SEK 1.53%
Market Cap: 7.8B SEK
Have any thoughts about
Swedencare AB (publ)?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

17
Current
21.5
Median
13.5
Industry
Lower than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
17
=
Enterprise Value
9.2B SEK
/
EBITDA
539.1m SEK
All Countries
Close
EBITDA Growth EV/EBITDA to Growth
SE
S
Swedencare AB (publ)
STO:SECARE
Average EV/EBITDA: 415.3
17
78%
0.2
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
48.5
195%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
151%
25.5
DK
Novo Nordisk A/S
CSE:NOVO B
20.2
84%
0.2
US
Johnson & Johnson
NYSE:JNJ
11.5
14%
0.8
US
Merck & Co Inc
NYSE:MRK
10.5
331%
0
CH
Roche Holding AG
SIX:ROG
9.8
23%
0.4
UK
AstraZeneca PLC
LSE:AZN
169.4
64%
2.7
CH
Novartis AG
SIX:NOVN
9.4
8%
1.2
US
Pfizer Inc
NYSE:PFE
10.6
31%
0.3

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
15.8
2-Years Forward
EV/EBITDA
12.7
3-Years Forward
EV/EBITDA
10.7

See Also

Discover More